268 related articles for article (PubMed ID: 32017522)
1. Targeted Covalent Inhibition of Telomerase.
Betori RC; Liu Y; Mishra RK; Cohen SB; Kron SJ; Scheidt KA
ACS Chem Biol; 2020 Mar; 15(3):706-717. PubMed ID: 32017522
[TBL] [Abstract][Full Text] [Related]
2. Identification of small molecule inhibitors of telomerase activity through transcriptional regulation of hTERT and calcium induction pathway in human lung adenocarcinoma A549 cells.
Rao YK; Kao TY; Wu MF; Ko JL; Tzeng YM
Bioorg Med Chem; 2010 Oct; 18(19):6987-94. PubMed ID: 20813535
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
5. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
6. Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.
Morais KDS; Arcanjo DDS; de Faria Lopes GP; da Silva GG; da Mota THA; Gabriel TR; Rabello Ramos DDA; Silva FP; de Oliveira DM
Cell Biochem Funct; 2019 Jun; 37(4):273-280. PubMed ID: 31012504
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors.
Plyasova AA; Berrino E; Khan II; Veselovsky AV; Pokrovsky VS; Angeli A; Ferraroni M; Supuran CT; Pokrovskaya MV; Alexandrova SS; Gladilina YA; Sokolov NN; Hilal A; Carta F; Zhdanov DD
J Med Chem; 2021 Aug; 64(15):11432-11444. PubMed ID: 34283610
[TBL] [Abstract][Full Text] [Related]
8. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
[TBL] [Abstract][Full Text] [Related]
9. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C
Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
11. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ
J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760
[TBL] [Abstract][Full Text] [Related]
12. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.
Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L
Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
14. Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition.
Sissi C; Lucatello L; Paul Krapcho A; Maloney DJ; Boxer MB; Camarasa MV; Pezzoni G; Menta E; Palumbo M
Bioorg Med Chem; 2007 Jan; 15(1):555-62. PubMed ID: 17035038
[TBL] [Abstract][Full Text] [Related]
15. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
17. Human telomerase inhibition by substituted acridine derivatives.
Harrison RJ; Gowan SM; Kelland LR; Neidle S
Bioorg Med Chem Lett; 1999 Sep; 9(17):2463-8. PubMed ID: 10498189
[TBL] [Abstract][Full Text] [Related]
18. Integration of NMR studies, computational predictions, and in vitro assays in the search of marine diterpenes with antitumor activity.
Forero AM; Castellanos L; Sandoval-Hernández AG; Magalhães A; Tinoco LW; Lopez-Vallejo F; Ramos FA
Chem Biol Drug Des; 2021 Oct; 98(4):507-521. PubMed ID: 34143939
[TBL] [Abstract][Full Text] [Related]
19. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
20. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
